SCHEMBL4119806

SCHEMBL4119806

CC(=O)C(C(C)=O)[C@@H](C[N+](=O)[O-])c1ccc(Br)cc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
CYP2C19 P33261 1/20 0.46
LMNA P02545 3/20 0.44
CYP1A2 P05177 1/20 0.41
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
KDM4E B2RXH2 2/20 0.38
MAPT P10636 2/20 0.38
APAF1 O14727 1/20 0.38
HSP90AA1 P07900 1/20 0.38
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
ATM Q13315 1/20 0.38
POLB P06746 1/20 0.36
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
BRD4 O60885 1/20 0.34
ALOX5 P09917 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16683404 1.00 ALDH1A1 (0.46) ALDH1A1CYP2C19LMNACYP1A2MEN1
SCHEMBL4126175 0.86 ALDH1A1 (0.47) ALDH1A1CYP2C19LMNAMEN1KMT2A
SCHEMBL16683401 0.86 ALDH1A1 (0.47) ALDH1A1CYP2C19LMNAMEN1KMT2A
SCHEMBL22831459 0.86 ALDH1A1 (0.44) ALDH1A1CYP2C19LMNAMEN1KMT2A
SCHEMBL16683403 0.84 BRD4 (0.53) ALDH1A1CYP2C19LMNAMEN1KMT2A
SCHEMBL16683402 0.84 ALDH1A1 (0.46) ALDH1A1CYP2C19LMNAMEN1KMT2A
SCHEMBL4120421 0.84 BRD4 (0.53) ALDH1A1CYP2C19LMNAMEN1KMT2A
SCHEMBL4111632 0.84 CPA1 (0.45) ALDH1A1CYP2C19LMNAMEN1KMT2A
SCHEMBL2628014 0.84 CPA1 (0.45) ALDH1A1CYP2C19LMNAMEN1KMT2A
SCHEMBL14338542 0.84 ALDH1A1 (0.66) ALDH1A1CYP2C19LMNACYP1A2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8084641-B2 Organocataslysts and methods of use in chemical synthesis STC.UNM (US) 2011-12-27 US disclosed
US-8084641-B2 Organocataslysts and methods of use in chemical synthesis STC.UNM (US) 2011-12-27 US disclosed
US-20090088588-A1 Organocatalysts and methods of use in chemical synthesis REGENTS OF THE UNIVERSITY OF NEW MEXICO 2009-04-02 US disclosed
US-20090088588-A1 Organocatalysts and methods of use in chemical synthesis REGENTS OF THE UNIVERSITY OF NEW MEXICO 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090088588-A1 Organocatalysts and methods of use in chemical synthesis ICMT, PPOX, CYP4F3 ALDH1A1 1418/4885CYP2C19 157/4885LMNA 4649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.